Angiotensin II Receptor Blocker Reduces Oxidative Stress and Attenuates Hypoxia-Induced Left Ventricular Remodeling in Apolipoprotein E-Knockout Mice
Open Access
- 1 January 2007
- journal article
- Published by Japanese Society of Hypertension in Hypertension Research
- Vol. 30 (12), 1219-1230
- https://doi.org/10.1291/hypres.30.1219
Abstract
Elevated superoxide formation in cardiac extracts of apolipoprotein E–knockout (apoE-KO) mice has been reported. In addition, we previously reported that hypoxia increased oxidative stress in the aortas of apoE-KO mice, although we did not examine the effect of hypoxia on the heart. The aim of this study was to investigate the effect of chronic hypoxia on the left ventricular (LV) remodeling in apoE-KO mice treated with or without an angiotensin II receptor blocker. Male apoE-KO mice (n=83) and wild-type mice (n=34) at 15 weeks of age were kept under hypoxic conditions (oxygen, 10.0±0.5%) and treated with olmesartan (3 mg/kg/day) or vehicle for 3 weeks. Although LV pressure was not changed, hypoxia caused hypertrophy of cardiomyocytes and increased interstitial fibrosis in the LV myocardium. Furthermore, nuclear factor-κB (NF-κB) and matrix metalloproteinase (MMP)-9 activities were increased in apoE-KO mice exposed to chronic hypoxia. Olmesartan effectively suppressed the 4-hydroxy-2-nonenal protein expression and NF-κB and MMP-9 activities, and preserved the fine structure of the LV myocardium without affecting the LV pressure. In conclusion, olmesartan reduced oxidative stress, and attenuated the hypoxia-induced LV remodeling, in part through the inhibition of NF-κB and MMP-9 activities, in apoE-KO mice.Keywords
This publication has 47 references indexed in Scilit:
- Obstructive sleep apnoea inhibits the recovery of left ventricular function in patients with acute myocardial infarctionEuropean Heart Journal, 2006
- Intermittent Hypoxia Induces Hyperlipidemia in Lean MiceCirculation Research, 2005
- Circulating cardiovascular risk factors in obstructive sleep apnoea: data from randomised controlled trialsThorax, 2004
- APOE ε4 is associated with obstructive sleep apnea/hypopneaNeurology, 2004
- Lung Function and Cardiovascular RiskCirculation, 2002
- Evidence for left ventricular dysfunction in patients with obstructive sleep apnoea syndrome.European Respiratory Journal, 2002
- Association Between Apolipoprotein E ∊4 and Sleep-Disordered Breathing in AdultsJAMA, 2001
- Changes in Intra-Abdominal Visceral Fat and Serum Leptin Levels in Patients With Obstructive Sleep Apnea Syndrome Following Nasal Continuous Positive Airway Pressure TherapyCirculation, 1999
- Obstructive Sleep Apnea as a Risk Marker in Coronary Artery DiseaseJMIR AI, 1999
- Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications.Circulation, 1990